Produkty 972-46-3

CAS 972-46-3 występuje w naszej ofercie pod nazwami: 3-Ethoxy-androsta-3,5-dien-17-one, Testosterone EP Impurity B, 3-Ethoxy-androsta-3,5-dien-17-one, >95% (HPLC). Oferty producentów: Biosynth, Chemat Brand, TRC, Mikromol. Dostępne opakowania: 100mg, 50mg, 250mg, 500mg, 1000mg, on request, 25mg.

3-Ethoxy-androsta-3,5-dien-17-one
Biosynth
  • opakowanie: 100mg, 50mg, 250mg, 500mg
  • Warianty: 5
Zobacz produkt
Testosterone EP Impurity B
Chemat Brand, Mikromol
  • opakowanie: on request, 25mg
  • Warianty: 2
Zobacz produkt
3-Ethoxy-androsta-3,5-dien-17-one, >95% (HPLC)
TRC
  • opakowanie: 100mg, 50mg
  • Warianty: 2
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(8R,9S,10R,13S,14S)-3-ethoxy-10,13-dimethyl-1,2,7,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-one (CAS 972-46-3) to związek chemiczny o wzorze sumarycznym C21H30O2 i masie molowej 314.5 g/mol. Nazwa systematyczna IUPAC: (8R,9S,10R,13S,14S)-3-ethoxy-10,13-dimethyl-1,2,7,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-one. InChIKey: PAOWPNQOTVTCAF-OEUJLIAZSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H30O2
Masa molowa314.5 g/mol
Nazwa IUPAC(8R,9S,10R,13S,14S)-3-ethoxy-10,13-dimethyl-1,2,7,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-one
InChIKeyPAOWPNQOTVTCAF-OEUJLIAZSA-N
SMILESCCOC1=CC2=CC[C@H]3[C@@H]4CCC(=O)[C@]4(CC[C@@H]3[C@]2(CC1)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 3-Ethoxyandrosta-3,5-dien-17-one, Androst-4-ene-3,17-dione 3-Ethyl Enol Ether, Testosterone impurity B [EP], Androsta-3,5-dien-17-one, 3-ethoxy-, TESTOSTERONE IMPURITY B [EP IMPURITY], TESTOSTERONE IMPURITY B (EP IMPURITY), Testosterone impurity B, 3-Ethoxy-androsta-3,5-dien-17-one, Testosterone EP Impurity B, Androstenedione Ethylenolether
Izomery (ten sam wzór sumaryczny)
1-[(3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H30O2
methyl (1R,4aS,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate C21H30O2
(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol C21H30O2
[(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-4,5,6,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C21H30O2
(8R,9S,13S,14S,17S)-13-methyl-3-propoxy-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-ol C21H30O2
4-[(6E)-3,7,11-trimethyldodeca-1,6,10-trien-3-yl]benzene-1,2-diol C21H30O2
(8S,9R,10S,13S,14S,17S)-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one C21H30O2
(6aR,10aS)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol C21H30O2
2-methyl-2-(4-methylpent-3-enyl)-7-pentylchromen-5-ol C21H30O2
(8S,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H30O2
[(3S,8S,9S,10R,14S)-10,17-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate C21H30O2
(8S,9R,10S,13S,14S,17S)-17-[(1S)-1-hydroxyethyl]-10,13-dimethyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one C21H30O2